GlassScriptPhysician profile
Andrew C Thomas
NPI 1710623301
$712.31
in general payments reported to CMS, 2019-2025
12 companies · $712 in 2025
The $712 reported for 2025 was more than what 80% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $712.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $695 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $694.93 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $148.60 | 2025 | Korlym |
| Lilly USA, LLC | $143.22 | 2025 | Jardiance, Kisunla, Amyvid |
| Astrazeneca Pharmaceuticals LP | $122.31 | 2025 | Airsupra |
| Inspire Medical Systems, INC. | $66.04 | 2025 | Inspire |
| Dexcom, INC. | $40.62 | 2025 | Dexcom G6 Transmitter |
| Amgen INC. | $35.13 | 2025 | Evenity |
| Exact Sciences Corporation | $31.90 | 2025 | The Cologuard Plus Collection Kit |
| Otsuka America Pharmaceutical, INC. | $29.19 | 2025 | Rexulti |
| Astellas Pharma US INC | $29.13 | 2025 | Veozah |
| Pfizer INC. | $25.61 | 2025 | |
| Eisai INC. | $23.18 | 2025 | |
| Insmed, INC. | $17.38 | 2025 | Brinsupri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.